Article
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
1 Jul 2021
Abstract excerpt
BACKGROUND: Therapies based on targeting immune checkpoints have revolutionized the treatment of metastatic melanoma in recent years. Still, biomarkers predicting long-term therapy responses are lacking. METHODS: A novel approach of reference-free deconvolution of large-scale DNA methylation data enabled us to develop a machine learning classifier based on CpG sites, specific for latent methylation components...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
